News & Analysis as of

False Claims Act (FCA) Trump Administration

Benesch

The “China Initiative” Just Won’t Die - Recent DOJ Settlement Highlights the Lasting Effect of Trump-Era Policy on Health Care...

Benesch on

In 2022, the United States Department of Justice (“DOJ”) announced its decision to shut down the “China Initiative”—the controversial program used to investigate and prosecute academics, health care workers, and...more

McDermott Will & Emery

McDermott’s Healthcare Enforcement Quarterly - Q1 2022

McDermott Will & Emery on

The healthcare enforcement landscape is shifting quickly. This issue of McDermott’s Healthcare Enforcement Quarterly examines emerging trends and key issues for organizations that may become subject to enforcement scrutiny,...more

Miles & Stockbridge P.C.

The Regulators Strike Back: How Does Compliance Respond?

Miles & Stockbridge P.C. on

The Department of Justice (DOJ) recently overturned the prior administration’s limitations on the use of regulatory guidance in False Claims Act (FCA) litigation. Now, DOJ attorneys may rely on guidance documents “in any...more

Cozen O'Connor

California Gets A New AG | $188.6 Million Surgical Mesh Settlement | Keystone Pipeline Litigation

Cozen O'Connor on

State AGs in the News- Governor Newsom Nominates Rob Bonta for California Attorney General- •Governor Gavin Newsom nominated California Assemblyman Rob Bonta to replace Xavier Becerra as California AG. Bonta’s...more

Cozen O'Connor

Impostor Government Invoices | Car Dealer Employees Working Without Pay? | Democratic AGs v. Trump Administration

Cozen O'Connor on

State AGs in the News- Alaska Governor Nominates Acting Attorney General to Be Attorney General- •Alaska Governor Mike Dunleavy nominated acting Alaska AG Clyde “Ed” Sniffen for the AG position. The nomination must be...more

White & Case LLP

Trump Administration’s Eleventh-Hour Drug Pricing Regulations Face an Uncertain Path Forward

White & Case LLP on

The Trump Administration recently announced two final rules that implement policy objectives to lower drug prices by tying certain Medicare Part B payments to prices paid by other countries and by replacing an anti-kickback...more

WilmerHale

Decoupling From China: Part 3 - Oversight And The Election

WilmerHale on

The COVID-19 pandemic and the serious supply chain vulnerabilities it exposed have led to a seismic shift in U.S. policy and regulation, from stepped-up measures to protect U.S. technology, intellectual property and data from...more

Cozen O'Connor

2020 Election Impact | Waste Management Merger Antitrust Concerns | NAAG Consumer Protection Conference Highlights

Cozen O'Connor on

Antitrust- What a Waste! Merging Waste Disposal Companies Must Divest Assets to Avoid Antitrust Concerns- •The U.S. Department of Justice (“DOJ”) and the AGs of Florida, Illinois, Minnesota, Pennsylvania, and Wisconsin...more

Epstein Becker & Green

False Claims Act Enforcement During the COVID-19 Pandemic and Beyond

Epstein Becker & Green on

Earlier this summer, Ethan P. Davis, Principal Deputy Assistant Attorney General for the Civil Division of the U.S. Department of Justice (DOJ) delivered remarks addressing DOJ’s top priorities for enforcement actions related...more

Jackson Walker

Telemedicine Fraud During COVID-19

Jackson Walker on

As a result of the Trump administration’s expanded Medicare telehealth coverage, providers are now able to offer and be reimbursed for a wider range of services provided via telemedicine. In light of the current COVID-19...more

Morgan Lewis

Defense Production Act, Rated Orders & the FCA: Long-Term Liability Amid a Current Crisis?

Morgan Lewis on

Companies complying with orders under the Defense Production Act should be aware, and prepared to manage, potential False Claims Act liability that arises with government funding. As the current global and national crisis of...more

Skadden, Arps, Slate, Meagher & Flom LLP

Drug Pricing Concerns Drive Continued DOJ Focus on Life Sciences Companies

In 2019, U.S. Department of Justice (DOJ) enforcement activity targeting drug and device manufacturers jumped sharply over the prior year, reflecting an increased focus on fraud and abuse in the life sciences sector. More...more

Foley Hoag LLP - White Collar Law &...

White Collar Year in Preview: False Claims Act Trends in 2020

Editors’ Note: This is the fourth in our start-of-year series examining important trends in white collar law and investigations in the coming year. Our previous entry discussed anti-corruption trends in 2020. Up next: a look...more

White & Case LLP

President Trump's trade wars and the expansion of customs violations into the white-collar space

White & Case LLP on

The US' ongoing trade wars—with various trading partners and particularly with China—are everywhere in the news. Putting politics and policy aside, the "trade wars" reflect a basic disagreement over the rules that should...more

Foley & Lardner LLP

Healthcare Law Review: Overview of the U.S. Healthcare System

Foley & Lardner LLP on

The U.S. healthcare industry remains at a crossroads. The healthcare reform legislation passed under President Barack Obama in 2010, officially called the Patient Protection and Affordable Care Act (ACA) but widely referred...more

PilieroMazza PLLC

Weekly Update Newsletter - October 2019 #2

PilieroMazza PLLC on

FALSE CLAIMS ACT / GOVERNMENT CONTRACTS LAW - Buyer Beware: More Stringent Standards for Government Contractors Under the Buy American Act on the Horizon - President Trump has made “buy American and hire American” a...more

Faegre Drinker Biddle & Reath LLP

Government Contractors May Face New Hurdles Under Trump’s Executive Order Increasing Buy American Act Requirements

President Donald Trump’s most recent effort to maximize the use of goods, products, and materials produced in the United States through proposed changes to and enforcement of the regulations implementing the Buy American Act...more

PilieroMazza PLLC

Weekly Update Newsletter- July 2019 #4

PilieroMazza PLLC on

SMALL BUSINESS PROGRAMS & ADVISORY SERVICES - CLIENT ALERT: SBA to Increase Size Standards with Inflationary Adjustment, July 17, 2019 - On July 18, 2019, SBA issued an interim final rule increasing the receipts-based...more

WilmerHale

Disputes Over the Government’s Qui Tam Dismissal Authority Explode Around the Country

WilmerHale on

Since the beginning of the Trump administration, and particularly in the last six months, the U.S. Department of Justice has been exercising its authority to dismiss qui tam False Claims Act cases with increasing frequency....more

Carlton Fields

They Really (Sorta) Mean it This Time: Three Things Private Companies Need to Know About Trump’s Second “Buy American” Executive...

Carlton Fields on

If your company receives money from the federal government, take note: President Trump signed another "Buy American, Hire American" Executive Order on January 31, 2019, ...more

Troutman Pepper

HHS Proposes 'Sweeping' Changes to Pharmacy Drug Pricing

Troutman Pepper on

The pharmacy benefit manager (PBM) industry recently has come under significant scrutiny by the Trump administration....more

PilieroMazza PLLC

Weekly Update Newsletter - February 2019

PilieroMazza PLLC on

GOVERNMENT CONTRACTING - According to a Washington Technology article, just because government agencies reopened after five weeks of a shutdown does not mean things return to business as usual. In fact, the article...more

Robins Kaplan LLP

Your Daily Dose of Financial News

Robins Kaplan LLP on

The European Union has fined Mastercard $650 million for “breaching antitrust rules by raising payment-processing fees artificially, leading to higher prices for retailers and consumers” alike. The penalty came after a 6-year...more

Skadden, Arps, Slate, Meagher & Flom LLP

Skadden's 2019 Insights: Trump Policy Actions Could Reshape Health Care and Life Sciences Landscape

In 2018, President Donald Trump and numerous executive branch agencies announced proposals that, if implemented, will reshape the landscape for virtually every sector of the health care industry. Many of these proposals are...more

PilieroMazza PLLC

Weekly Update Newsletter - December 2018 #4

PilieroMazza PLLC on

GOVERNMENT CONTRACTING - According to a Bloomberg Government article, more than 30,000 federal contracting opportunities at twenty-eight (28) agencies are coming up for competition in the coming fiscal years. In a webinar,...more

62 Results
 / 
View per page
Page: of 3

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide